TCTMD

TMD is a leading online platform dedicated to interventional cardiology, offering extensive insights into the percutaneous management of heart conditions. Since its debut at TCT 2000, TCTMD has been a valuable resource for healthcare providers and industry stakeholders, providing updates on the fast-changing landscape of cardiovascular medicine. Users can access news and information from global conferences, along with the latest advancements in devices and medications that are essential in everyday cardiology practice. TCTMD is managed by the Cardiovascular Research Foundation (CRF), which is committed to enhancing the quality of life for individuals with cardiovascular issues. CRF aims to promote the development and application of safe, effective, and minimally invasive treatments for heart disease. For further details, please visit our website at http://www.crf.org.

National, Trade/B2B

English, Spanish

Online/Digital

Outlet metrics

Domain Authority

Ranking

Global

#303367

United States

#131864

Health/Medicine

#1090

Traffic sources

Monthly visitors

Articles

Solid Durability Seen With Surgical Resilia Tissue Aortic Valve

3 days ago | tctmd.com | Yael L. Maxwell

News Conference News HVS 2025 The 8-year data may hold value for TAVI—the newest Sapien valve uses the same tissue—but many other variables differ. Surgical bioprosthetic aortic valves made with bioengineered Resilia tissue (Edwards Lifesciences) appear to suffer less structural deterioration over 8 years compared with similar devices made of traditional bovine pericardial tissue, according to new data.
High-Sensitivity Troponin Tests Might Aid in Primary Prevention

1 week ago | tctmd.com | Yael L. Maxwell

Added information from the assays could guide care, especially for intermediate-risk patients on the cusp of initiating statins. Adding high-sensitivity cardiac troponin assays on top of conventional risk-prediction methods can potentially improve primary prevention efforts, according to a new meta-analysis. While best known for their ability to rule out or diagnose MI, these assays also can quantify very low concentrations of cardiac troponin T and I in otherwise healthy people.
DETECT-AS: Alert System Increases AV Replacement in Eligible Patients

1 week ago | tctmd.com | Michael O'Riordan

News Conference News ACC 2025 The “passive” notification led to more patients with severe AS undergoing valve replacement, but more can be done still. CHICAGO, IL—A personalized alert system that informs healthcare providers about the detection of severe aortic stenosis on echocardiography and provides recommendations around patient management appears to improve the quality of aortic valve care, according to results from the DETECT-AS study.
Cardiologists Plot Next Moves After New Board Rejected

1 week ago | tctmd.com | Yael L. Maxwell

News Conference News ACC 2025 The ABCVM wanted to certify cardiologists outside of ABIM, but the recent denial doesn’t mean their efforts have stopped.
COMPARE-TAVI 1: Myval Performs Well Against Sapien at 1 Year

1 week ago | tctmd.com | Todd Neale

There’s room on the market for new TAVI valves as long as they can compete with the best in practice, a researcher says. As legal battles continue between the manufacturers, the COMPARE-TAVI 1 trial has demonstrated that the Myval and Myval Octacor transcatheter heart valves (Meril Life Sciences) compare favorably with Sapien 3 devices (Edwards Lifesciences) in patients with severe aortic stenosis.
Weekend Warriors Also See Mortality Benefits With Exercise

2 weeks ago | tctmd.com | Michael O'Riordan

The study is the latest showing that it doesn’t matter how exercise gets done in a week, as long as it gets done. Concentrating the weekly recommended amount of moderate-to-vigorous physical activity (MVPA) over a couple of days is associated with a significantly lower risk of mortality when compared with inactivity, and a similarly low risk of mortality when contrasted with a more evenly spread-out pattern, according to a new analysis.
Aditya Mehta, MBBS

2 weeks ago | tctmd.com | Yael L. Maxwell

The dynamic field of advanced heart failure, and helping these patients live comfortably, has inspired this fellow. Aditya Mehta, MBBS, is a third-year general cardiology fellow at Inova Schar Heart and Vascular in Fairfax, VA.
SWISS-APERO at 3 Years: Hints of Differences Between Amulet, Watchman Emerge

2 weeks ago | tctmd.com | Todd Neale

News Conference News EHRA 2025 Though ischemic outcomes numerically favored the Amulet, confirmation in future studies is needed, experts say. VIENNA, Austria—There may be potential differences in ischemic outcomes between the two most frequently used devices for left atrial appendage occlusion (LAAO) in patients with atrial fibrillation (AF), according to follow-up data from the SWISS-APERO study.
FDA Drops REMS Requirement for Antihypertensive Aprocitentan

2 weeks ago | tctmd.com | Michael O'Riordan

The drug was approved last year for patients with hypertension currently not controlled on other BP-lowering agents. The US Food and Drug Administration will no longer require aprocitentan (Tryvio), a novel endothelin receptor antagonist, to be part of its drug safety program, according to an announcement from manufacturer Idorsia Pharmaceuticals.
AHA Tackles Need for Increased CV Prevention in Emerging Adults

2 weeks ago | tctmd.com | Yael L. Maxwell

The transition from adolescence can bring decreased physical activity, a worse diet, and little focus on overall CV health. As the prevalence of cardiovascular disease rises in young adults, clinicians need to shift their focus toward more intentional prevention efforts in those emerging from adolescence, according to a scientific statement from the American Heart Association.